Has Terence Hill, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,407 in general payments to Terence Hill, MD across 135 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Terence Hill, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Terence Hill, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Terence Hill, MD

Interventional Cardiology · Concord, NCNPI 1063701019

Payments from drug & device makers

$10,407in general payments, 2019–2025

Across 135 payments — averaging $77.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$3K
Abbott$2K
Medtronic$2K
Boston Scientific$2K
Teleflex LLC$427
Philips North America LLC$277
plus $929 from 10 others

$108in research payments, 2019–2025

Across 1 payment — averaging $108.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abiomed$108

What the payments were for

Travel & lodging$2,66226%
Food & beverage$7,74574%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	36	$2,521
Abbott	22	$2,297
Medtronic(2 entities)	28	$2,161
Boston Scientific	26	$1,796
Teleflex LLC	4	$427
Philips North America LLC	5	$277
Abiomed	2	$239
Inari Medical, Inc.	2	$235
Biotronik Inc.	1	$128
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$83
Shockwave Medical, Inc	1	$72
Siemens Medical Solutions USA, Inc.	1	$57
W. L. Gore & Associates, Inc.	2	$41
Imperative Care, Inc	1	$32
Stryker	1	$22
Angiodynamics, Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MitraClip$1,292
CoreValve Evolut$937
Edwards SAPIEN 3 Transcatheter Heart Valve$715
AVVIGO Guidance System$471
SAPIEN 3 Ultra RESILIA$406
COREVALVE EVOLUT R$249
Resolute$239
FLOWTRIEVER CATHETER, S$208
CT THROMBECTOMY SYSTEM KIT$208
OPTIS$186
GENERAL - THERAPIES$150
Impella$144
US Und$143
GENERAL - STRUCTURAL HEART$141
AMPLATZER Occluders$141
WATCHMAN Access System$139
GUIDELINER$130
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$125
Watchman$115
WATCHMAN FLX$112

How this compares

$10,407 in reported general payments places this provider in the 50th percentile of 180 interventional cardiology providers in North Carolina.

See all interventional cardiology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$176,493

Medicare patients

394

Services billed

1,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	57	$48,211
Repatha SureclickEvolocumab	31	$28,435
BrilintaTicagrelor	16	$7,775
FarxigaDapagliflozin Propanediol	11	$7,389
ClopidogrelClopidogrel Bisulfate	153	$1,292
Isosorbide Mononitrate ErIsosorbide Mononitrate	67	$644
Atorvastatin Calcium	78	$608
Nitroglycerin	32	$371
Ezetimibe	14	$297
Amlodipine Besylate	41	$270
Carvedilol	38	$259
Nifedipine ErNifedipine	19	$255
Metoprolol Succinate	34	$218
Furosemide	49	$212
Rosuvastatin Calcium	20	$206

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Concord

Ravish SacharRaleigh$10.1M
George AdamsGarner$5.2M
Paul MahoneyGreenville$3.9M
Oluseun AlliCharlotte$2.3M
Patrick SimpsonPinehurst$1.6M
Matthew CavenderChapel Hill$1.5M
Rajesh SwaminathanDurham$1.4M
Steven FilbyPinehurst$1.3M
John PasquiniCharlotte$1.3M
James ZidarRaleigh$1.1M

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →